Literature DB >> 33668239

Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia without Invasive Carcinoma.

Ryota Sagami1,2, Kentaro Yamao2,3, Jun Nakahodo2,4, Ryuki Minami2,5, Masakatsu Tsurusaki6, Kazunari Murakami7, Yuji Amano8.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) arises from precursor lesions, such as pancreatic intra-epithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN). The prognosis of high-grade precancerous lesions, including high-grade PanIN and high-grade IPMN, without invasive carcinoma is good, despite the overall poor prognosis of PDAC. High-grade PanIN, as a lesion preceding invasive PDAC, is therefore a primary target for intervention. However, detection of localized high-grade PanIN is difficult when using standard radiological approaches. Therefore, most studies of high-grade PanIN have been conducted using specimens that harbor invasive PDAC. Recently, imaging characteristics of high-grade PanIN have been revealed. Obstruction of the pancreatic duct due to high-grade PanIN may induce a loss of acinar cells replaced by fibrosis and lobular parenchymal atrophy. These changes and additional inflammation around the branch pancreatic ducts (BPDs) result in main pancreatic duct (MPD) stenosis, dilation, retention cysts (BPD dilation), focal pancreatic parenchymal atrophy, and/or hypoechoic changes around the MPD. These indirect imaging findings have become important clues for localized, high-grade PanIN detection. To obtain pre-operative histopathological confirmation of suspected cases, serial pancreatic-juice aspiration cytologic examination is effective. In this review, we outline current knowledge on imaging characteristics of high-grade PanIN.

Entities:  

Keywords:  endoscopic ultrasound; high-grade; intraductal papillary mucinous neoplasm; pancreatic cancer; pancreatic duct; pancreatic ductal adenocarcinoma; pancreatic intra-epithelial neoplasia; pancreatic juice cytology; parenchymal atrophy

Year:  2021        PMID: 33668239     DOI: 10.3390/cancers13050945

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  2 in total

1.  Diagnostic Strategy of Early Stage Pancreatic Cancer via Clinical Predictor Assessment: Clinical Indicators, Risk Factors and Imaging Findings.

Authors:  Ryota Sagami; Takao Sato; Kazuhiro Mizukami; Mitsuteru Motomura; Kazuhisa Okamoto; Satoshi Fukuchi; Yuichiro Otsuka; Takashi Abe; Hideki Ono; Kei Mori; Kurato Wada; Tomoyuki Iwaki; Hidefumi Nishikiori; Koichi Honda; Yuji Amano; Kazunari Murakami
Journal:  Diagnostics (Basel)       Date:  2022-02-01

Review 2.  Therapeutic Aspects and Molecular Targets of Autophagy to Control Pancreatic Cancer Management.

Authors:  Md Ataur Rahman; Kazi Rejvee Ahmed; M D Hasanur Rahman; Md Anowar Khasru Parvez; In-Seon Lee; Bonglee Kim
Journal:  Biomedicines       Date:  2022-06-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.